Literature DB >> 9434207

The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test.

J W Smythe1, S Bhatnagar, D Murphy, C Timothy, B Costall.   

Abstract

Hippocampal cholinergic projections mediate attention to arousing stimuli as demonstrated by behavioral, electrophysiological, and endocrine studies. We recently reported that peripheral injections of the cholinergic antagonist scopolamine (SCOP) increased anxiety-like behaviour (ALB) in rats and we sought to investigate if this response might be hippocampally mediated. Adult male, Lister Hooded rats were implanted bilaterally with hippocampal cannulae 3 weeks prior to testing. On the test day, rats were injected with vehicle (VEH; artificial CSF at 3 microl), 15 or 30 microg SCOP, 20 min prior to being placed into the white chamber of the black-white box (n = 10/group). Rats were scored for latencies to exit and reenter the white chamber, total time spent in the white chamber, intercompartmental crossings, and activity. SCOP at 30 microg significantly reduced time to exit the white arena, while both doses of SCOP elevated latencies to reenter the white chamber. There were no effects of SCOP on intercompartmental crossing, time spent in the white chamber, or on activity levels. Loss of hippocampal cholinergic function impairs processing of threatening stimuli that manifests itself as increased ALB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9434207     DOI: 10.1016/s0361-9230(97)00311-0

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  14 in total

1.  Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.

Authors:  M Carli; C Balducci; R Samanin
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 2.  Maternal programming of defensive responses through sustained effects on gene expression.

Authors:  Josie Diorio; Michael J Meaney
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

3.  S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.

Authors:  M Carli; C Balducci; M J Millan; P Bonalumi; R Samanin
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Measures of anxiety, amygdala volumes, and hippocampal scopolamine phMRI response in elderly female rhesus macaques.

Authors:  Gwendolen E Haley; Acacia McGuire; Daphnee Berteau-Pavy; Alison Weiss; Roshni Patel; Ilhem Messaoudi; Henryk F Urbanski; Jacob Raber
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

Review 5.  Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.

Authors:  Susanne Graef; Peter Schönknecht; Osama Sabri; Ulrich Hegerl
Journal:  Psychopharmacology (Berl)       Date:  2011-01-08       Impact factor: 4.530

6.  Roles of p75(NTR), long-term depression, and cholinergic transmission in anxiety and acute stress coping.

Authors:  Keri Martinowich; Robert J Schloesser; Yuan Lu; Dennisse V Jimenez; Daniel Paredes; Joshua S Greene; Nigel H Greig; Husseini K Manji; Bai Lu
Journal:  Biol Psychiatry       Date:  2011-10-05       Impact factor: 13.382

7.  Short- and long-term anxiogenic effects induced by a single injection of subconvulsant doses of pilocarpine in rats: investigation of the putative role of hippocampal pathways.

Authors:  Filipe Silveira Duarte; Elaine Cristina Gavioli; Marcelo Duzzioni; Alexandre Ademar Hoeller; Newton Sabino Canteras; Thereza Christina Monteiro De Lima
Journal:  Psychopharmacology (Berl)       Date:  2010-08-28       Impact factor: 4.530

8.  Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial.

Authors:  Kate R Kuhlman; Michael Treanor; Gabriella Imbriano; Michelle G Craske
Journal:  Psychoneuroendocrinology       Date:  2020-03-20       Impact factor: 4.905

9.  Increased noradrenaline levels in the rostral pons can be reversed by M1 antagonist in a rat model of post-traumatic stress disorder.

Authors:  Berna Terzioğlu; Melisa Kaleli; Banu Aydın; Sema Ketenci; Hülya Cabadak; M Zafer Gören
Journal:  Neurochem Res       Date:  2013-05-17       Impact factor: 3.996

10.  Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior.

Authors:  Yann S Mineur; Adetokunbo Obayemi; Mattis B Wigestrand; Gianna M Fote; Cali A Calarco; Alice M Li; Marina R Picciotto
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.